Literature DB >> 7622936

On the role of cholecystokinin in pancreatic cancer.

M K Herrington1, T E Adrian.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7622936     DOI: 10.1007/BF02788530

Source DB:  PubMed          Journal:  Int J Pancreatol        ISSN: 0169-4197


× No keyword cloud information.
  120 in total

1.  Cholecystokinin is responsible for growth of the pancreas after pancreaticobiliary diversion in rats.

Authors:  T Gasslander; J Axelson; R Håkanson; I Ihse; I Lilja; J F Rehfeld
Journal:  Scand J Gastroenterol       Date:  1990-10       Impact factor: 2.423

2.  Regulation of growth and differentiation in pancreatic cancer. Bethesda, Maryland, September 19 and 20, 1988.

Authors: 
Journal:  Pancreas       Date:  1989       Impact factor: 3.327

3.  A pilot clinical trial of the cholecystokinin receptor antagonist MK-329 in patients with advanced pancreatic cancer.

Authors:  J L Abbruzzese; C F Gholson; K Daugherty; E Larson; R DuBrow; R Berlin; B Levin
Journal:  Pancreas       Date:  1992       Impact factor: 3.327

4.  Growth effects of regulatory peptides on human pancreatic cancer lines PANC-1 and MIA PaCa-2.

Authors:  R M Liehr; G Melnykovych; T E Solomon
Journal:  Gastroenterology       Date:  1990-06       Impact factor: 22.682

5.  Effects of pancreaticobiliary diversion and gastric fundectomy on azaserine-induced pancreatic carcinogenesis in the rat.

Authors:  M Chu; L Franzén; S Sullivan; J F Rehfeld; I Ihse; K Borch
Journal:  Pancreas       Date:  1993-05       Impact factor: 3.327

6.  Trophic effects of unsulfated cholecystokinin on mouse pancreas and human pancreatic cancer.

Authors:  E B Heald; S T Kramer; J P Smith
Journal:  Pancreas       Date:  1992       Impact factor: 3.327

7.  Stimulation of growth of azaserine-induced putative preneoplastic lesions in rat pancreas is mediated specifically by way of cholecystokinin-A receptors.

Authors:  S P Povoski; W Zhou; D S Longnecker; B D Roebuck; R H Bell
Journal:  Cancer Res       Date:  1993-09-01       Impact factor: 12.701

8.  Glucocorticoids increase cholecystokinin receptors and amylase secretion in pancreatic acinar AR42J cells.

Authors:  C D Logsdon
Journal:  J Biol Chem       Date:  1986-02-15       Impact factor: 5.157

9.  Inhibition of intraduodenal trypsin does not stimulate exocrine pancreatic secretion in man.

Authors:  J Dlugosz; U R Fölsch; W Creutzfeldt
Journal:  Digestion       Date:  1983       Impact factor: 3.216

10.  [Effects of UFT and loxiglumide (CR1505) on liver metastasis of human pancreatic cancer cell line, KP-1 N in nude mice].

Authors:  T Shimazoe; A Funakoshi; A Kono
Journal:  Gan To Kagaku Ryoho       Date:  1992-08
View more
  2 in total

1.  Cholecystokinin A and B receptors are differentially expressed in normal pancreas and pancreatic adenocarcinoma.

Authors:  D S Weinberg; B Ruggeri; M T Barber; S Biswas; S Miknyocki; S A Waldman
Journal:  J Clin Invest       Date:  1997-08-01       Impact factor: 14.808

2.  Pharmacological profile of TP-680, a new cholecystokininA receptor antagonist.

Authors:  T Akiyama; I Tachibana; Y Hirohata; H Shirohara; M Yamamoto; M Otsuki
Journal:  Br J Pharmacol       Date:  1996-04       Impact factor: 8.739

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.